Trial Summary
What is the purpose of this trial?The purpose of the study is to evaluate the use of high flow nasal cannula versus standard oxygen therapy for high-risk patients undergoing endoscopy procedures.
Eligibility Criteria
This trial is for high-risk patients needing an endoscopy procedure. Specific eligibility criteria are not provided, but typically participants would need to meet certain health standards and may be excluded based on factors like other medical conditions or treatments that could interfere with the study.Inclusion Criteria
• All patients age 18 years and older who present to Gonda 2 procedural area for Endoscopic ultrasound (EUS) with or without endoscopy (EGD)/biopsy/tissue sampling. with BMI ≥ 35 kg/m2 (BMI within the past 6 months in electronic medical records or at current procedure) who are able to consent will be approached for potential enrollment.
Treatment Details
The study is comparing two ways of delivering oxygen during an endoscopy: a high flow nasal cannula versus standard oxygen therapy. The goal is to see which method works better for patients who are considered at higher risk.
2Treatment groups
Experimental Treatment
Active Control
Group I: High Flow Nasal CannulaExperimental Treatment1 Intervention
A high flow oxygen device with 100% FiO2 will be initiated prior to endoscopic ultrasound.
Group II: Standard oxygen therapyActive Control1 Intervention
Standard oxygen therapy will be initiated utilizing 2-4 liters of oxygen with a nasal cannula.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Mayo ClinicRochester, MN
Loading ...
Who is running the clinical trial?
Mayo ClinicLead Sponsor
Fisher and Paykel HealthcareIndustry Sponsor